Arthritis in children with LRBA deficiency - case report and literature review.

Pediatr Rheumatol Online J

Section of Pediatric Rheumatology, University of Chicago Medical Center, 5841 South Maryland Avenue, Room C101, MC, Chicago, IL, 5044, USA.

Published: December 2019

Background: Lipopolysaccharide (LPS)-responsive and beige like anchor (LRBA) deficiency is categorized as a subtype of common variable immune deficiency (CVID). A growing number of case reports and cohorts reveal a broad spectrum of clinical manifestations and variable phenotype expression, including immune dysregulation, enteropathy and recurrent infections. The association between rheumatic disease and CVID generally has been well established, arthritis has been less frequently reported and minimal data regarding its clinical features and characteristic in LRBA deficiency has been published. This case report and literature review evaluates the characteristics and features of arthritis in LRBA deficiency patients.

Case Presentation And Review Results: Herein, we describe a unique case of LRBA deficiency first presented with poly articular arthritis. Alongside the report, a literature review focusing on LRBA deficiency, rheumatic disease and arthritis has been conducted. We reviewed 43 publications. Among these, 7 patients were identified with arthritis. Age of first presentation was six weeks to 3 years. Male to female ratio was 4/3. Two patients were diagnosed with polyarticular Juvenile idiopathic arthritis (JIA) and three with oligoarticular JIA. Each patient was found to have different genomic mutation. The treatment was diverse and included corticosteroids, cyclosporine, methotrexate, adalidumab and abatacept.

Conclusion: Joint involvement is variable in LRBA deficiency, hence it should always be kept in mind as a differential diagnosis for a patient with combination of juvenile arthritis and clinically atypical immune dysregulation and / or immunodeficiency.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918552PMC
http://dx.doi.org/10.1186/s12969-019-0388-4DOI Listing

Publication Analysis

Top Keywords

lrba deficiency
28
report literature
12
literature review
12
arthritis
8
deficiency
8
case report
8
immune dysregulation
8
rheumatic disease
8
lrba
7
arthritis children
4

Similar Publications

Unmasking inborn errors of immunity: identifying the red flags of immune dysregulation.

Front Immunol

January 2025

Pediatrics Clinic and Institute for Molecular Medicine "A. Nocivelli", Department of Clinical and Experimental Sciences, University of Brescia and ASST-Spedali Civili di Brescia, Brescia, Italy.

Inborn errors of immunity (IEI) are rare diseases that affect the immune system. According to the latest International Union of Immunological Societies (IUIS) classification, 485 different IEI have been identified. Even if increased susceptibility to infections is the best-known symptom, IEI are no longer defined by the higher likelihood of infections alone.

View Article and Find Full Text PDF

Deleterious mutations in the lipopolysaccharide responsive beige-like anchor protein (LRBA) gene cause severe childhood immune dysregulation. The complexity of the symptoms involving multiple organs and the broad range of unpredictable clinical manifestations of LRBA deficiency complicate the choice of therapeutic interventions. Although LRBA has been linked to Rab11-dependent trafficking of the immune checkpoint protein CTLA-4, its precise cellular role remains elusive.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on a case involving a 49-year-old woman diagnosed with rheumatoid arthritis and subsequent severe immune deficiency due to a homozygous mutation in the LRBA gene, which is crucial for immune regulation.
  • The patient showed various symptoms, including massive splenomegaly, portal hypertension, and a rare type of cystitis associated with mast cells, indicating a complex clinical presentation.
  • This case emphasizes the importance of understanding LRBA's role in immune function and the diverse clinical manifestations linked to its deficiency.
View Article and Find Full Text PDF

LRBA deficiency is an inborn error of immunity defined by autoimmunity, lymphoproliferation, recurrent infections, cytopenia, and inflammatory bowel disease. Despite recent advances in managing this disease with targeted biologic therapy, haematopoietic stem cell transplant (HSCT) remains the only cure. However, great variability exists between protocols used to transplant patients with LRBA deficiency.

View Article and Find Full Text PDF

Homozygous mutations in the lipopolysaccharide-responsive vesicle trafficking, beach- and anchor-containing () gene lead to a syndrome characterized by early-onset hypogammaglobulinemia, autoimmunity, lymphoproliferation, and inflammatory bowel disease. This report describes a 10-year-old female who experienced three seizure episodes, including two generalized tonic-clonic seizures (GTCS) and one focal seizure, alongside septic shock. The patient had a history of recurrent respiratory tract infections, inflammatory bowel disease, multiple blood transfusions, lymphadenopathy, significant organomegaly, and hematological abnormalities, all consistent with an deficiency.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!